I fully agree with Nick. Ovarian cancer is an example of where it is difficult, and very often, we find that patients with ovarian cancer are diagnosed at stage 4. Friends of ours were similarly in that position and unfortunately, she passed away. It is a situation where we have to address how we tackle the hard-to-find cancers. And I was just about to highlight one example of such a hard-to-find cancer, but it is important that we put the emphasis on that as well to ensure that we look at new and innovative measures and techniques that'll do that. I'll give one example, because one of the major factors about lung cancer is that 27 per cent of lung cancer diagnoses are made at the earliest opportunity—27 per cent—so that's three quarters that aren't, which means that three quarters are diagnosed at stages 3 or 4.

Now, the publication, actually, only this year, January 2020, of what is known as the NELSON study—a study undertaken between researchers in the Netherlands and Belgium—confirmed that evidence supported that targeted lung cancer screening can actually help identify it sooner. Now, it's new and it's a pilot scheme that is being operated, but perhaps we in Wales could take on such new, innovative schemes such as this where there has been research that has shown that, actually, this is an approach that can work. And this approach is actually early screening by CT scanning. That is one of the ways that are suggested are better; we used to do it by x-rays, but now CT scanning can actually do it better. Could we look at a pilot approach and at that example and take it on in Wales, and be leading on tackling the situation, be leading in the UK and be leading in Europe, looking at how we can use innovative techniques and modern technology to actually help us do that early diagnosis? I'm sure that we're going to find similar areas, whether it be ovarian, pancreatic and others, that have very late diagnoses as well.

So, since the introduction of the cancer delivery plan, the Welsh Government announced in 2018 its decision to implement a single cancer pathway, which came into operation in June last year. As a result, every Welsh health board is now developing a plan to ensure that the majority of their patients, from the very first point that cancer might be suspected, receive cancer diagnostic tests and start their treatment within 62 days. Equally, for those patients who do not have cancer, they will be reassured promptly, reducing unnecessary stress and worry for those individuals and their families. The single cancer pathway is the culmination of more than three years of work to change our health boards' identifying and reporting of cancers, and to improve patients' cancer experiences. For the first time, health boards record how long patients wait from the point when cancer is first suspected regardless of the way they enter the healthcare system. The next cancer strategy must build on this to identify areas of improvement under the single cancer pathway to diagnose and treat as many patients as early as possible. So, we have started, but we need to do more.

Additionally, we need to ensure that the screening uptake is improving. Now, cervical cancer is clearly one that we often talk about, or maybe not in this case, and we should do more. But when the Jade Goody effect took place, we saw a surge in screening requirements following her death. Unfortunately, that has now waned, despite the tremendous work of cancer charities, such as Jo's Cervical Cancer Trust. We must ensure that these vital tests are taken by all those who are eligible. Cervical cancer screening every five years has led to a 70 per cent reduction in deaths from cancer. So, we need to do more to undertake and get screening accepted by wider people. We often talk in this Chamber about bowel cancer screening and the low take-up on that and the high take-up on breast cancer screening. We need to press this and a strategy to address this far more.

But we can do more by moving with the times and using technological advancements for the benefit of patients, and ensure that all have access to the most up-to-date and most accurate test to ensure that those who are affected by cancer are treated swiftly and in the best manner for their diagnosis.

Dirprwy Lywydd, I'm watching my time and I'll make sure that Angela has sufficient time to respond. So, I'll close a little earlier than I would have, but I want to close by reminding Members of the fantastic workforce we have in the NHS here in Wales. It's a workforce that works tirelessly to ensure that all patients have the best experience, no matter what their diagnosis. But we must recognise the pressures they're under. One of the things that we often heard in previous questions on the current cancer delivery plan was identifying the key worker in this whole thing, because that key worker is crucial to the patient and to the outcomes for that patient. Again, we must support both the patient and the workforce because they support the patient, and we must support the patient during diagnosis, during treatment and after treatment. Let's not forget when they survive as well. I look forward to the contributions this afternoon, Dirprwy Lywydd. Diolch yn fawr iawn. I hope that Members will support this motion.